Circulation · 16 Nov 2026
Biatrial Versus Left Atrial Maze Ablation During Cardiac Valve Surgery for Persistent Atrial Fibrillation: The ABLATION Trial
Zhongchen Lih-index 4, Chunyu Yu, Haojie Li, Yang Wang, Yongfeng Shao, Jinping Liu, Jianglong Hou, Zhi Fang, Zhi Lin, Hui Xiong, Huiming Guo, Liang Ma, Fei Li, Xiaoqi Wang, Shuiyun Wang, Xiaopeng Hu, Fei Xu, Xin Yuan, Zhaoyun Cheng, Ziniu Zhao, Jue Wang, Sheng Liu, Yan Yang, Ye Kong, Qing Zhou, Jun Pan, Zhigang Liu, Yukui Du, Xin Chen, Hai Tian, Heng Zhang, Ying Zhang, Yan Zhao, Liming Liu, Zhe Zhengh-index 11
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
BACKGROUND: Guidelines recommend concomitant surgical ablation during cardiac surgery in patients with atrial fibrillation (AF). However, the optimal lesion set remains uncertain, with ongoing debate regarding the relative benefits and risks of biatrial versus left atrial (LA) maze ablation. METHODS: In this multicenter, randomized, single-blind trial, patients with persistent or long-standing persistent AF undergoing rheumatic mitral valve surgery, with or without concomitant cardiac surgical procedures, were randomly assigned in a 1:1 ratio to undergo biatrial or LA maze ablation. The biatrial group underwent a complete Cox-Maze IV procedure; the LA group received a left-sided maze lesion set. To ensure standardization and consistency of the ablation procedures, surgeons underwent pretrial training and certification, and all procedures were videorecorded and centrally reviewed. The primary outcome was freedom from atrial tachyarrhythmias lasting >30 seconds without antiarrhythmic drugs within 12 months. The key secondary end point was freedom from permanent pacemaker implantation. RESULTS: All 323 randomized patients were included in the intention-to-treat analysis (mean age, 56.5 years; 72.1% women; mean LA diameter, 51.9 mm). At 12 months, 78.7% of patients (129 of 164) in the biatrial group and 68.6% (109 of 159) in the LA group were free from atrial tachyarrhythmias (adjusted difference, 10.7% [1-sided lower 95% CI, 3%]; P =0.01). Freedom from permanent pacemaker implantation was noted in 97.0% (159 of 164) of the biatrial group and 98.1% (156 of 159) of the LA group, meeting the predefined noninferiority criterion with a margin of −5% (adjusted difference, –1.1% [1-sided lower 95% CI, –3.9%]; P noninferiority =0.01). CONCLUSIONS: Among patients with persistent or long-standing persistent AF undergoing rheumatic cardiac valve surgery, biatrial maze ablation was superior to LA maze ablation in reducing recurrent atrial tachyarrhythmias, while maintaining noninferiority with respect to permanent pacemaker implantation. These findings provide direct evidence to inform lesion-set selection for surgical ablation during cardiac surgery. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05021601.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Zhe Zheng has the highest h-index among the authors (11).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (39)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 19 more references
A free account opens the rest of the citing papers and references on every paper’s page.